Skip to main content

Table 3 Intraoperative and surgical outcomes

From: Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study

  Control group (n = 15) Prehabilitation group (n = 14) p-value
Surgical approach
 Laparoscopic 2 (13.3) 0 (0) 0.157
 Laparotomic 13 (86.7) 14 (100)
Intestinal resection 1 (6.7) 2 (14.3) 0.501
Epidural anesthesia 11 (73.3) 11 (78.6) 0.742
Surgical time (min) mean ± SD 309.0 ± 76.7 300.0 ± 87.7 0.770
Aletti’s SCS, mean ± SD 5.0 ± 1.2 5.1 ± 2.6 0.927
Intraoperative blood transfusion 8 (53.3) 2 (14.3) 0.027
Intraoperative vasoactive drugs 3 (20.0) 1 (7.1) 0.316
Intraoperative complications 6 (40.0) 2 (14.3) 0.122
 Vascular 3 (20.0) 1 (7.1) 0.316
 Intestinal 2 (13.3) 1 (7.1) 0.584
 Urological 1 (6.7) 1 (7.1) 0.960
 Cardiovascular 0 (0) 0 (0) -
  1. Data are presented as n (%), unless otherwise specified
  2. SCS surgical complexity score, SD standard deviation